Environmental tobacco smoke (ETS) contaminates indoor air in homes and workplaces. Although the adverse effects of active cigarette smoking on the respiratory tract have been extensively characterized, the effects of ETS exposure on adult asthma have not yet been investigated extensively and the available data are limited. This article examines the evidence for ETS exposure as a cause of asthma and asthma exacerbation in adults, and for ETS exposure in the workplace specifically as contributing to these health effects. It addresses methodological barriers that limit the available data and evaluates the adequacy of the data for risk assessment.
107(suppl 6):891-895 (1999). http.//ehpnetl.niehs.nih.gov/docs/1999/suppl-6/891-895weiss/abstract.html This article addresses the relevant data on the relationship of environmental tobacco smoke (ETS) exposure to asthma in adults. The studies considered in this review were identified through a comprehensive literature search strategy as well as through recent comprehensive summaries of the literature, including the 1997 report of the California Environmental Protection Agency (1) and other reviews (2, 3) .
Specific questions to be considered include a) whether there are data supporting ETS as a cause of asthma in adults and if there is information specifically related to workplace exposure, and b) whether there are data indicating that ETS exposure is associated with exacerbations of asthma in adults. These questions represent an appropriate starting point for determining if the data are sufficient for a quantitative risk assessment to be conducted on the effects of workplace exposure to ETS on asthma in adults. There is substantial literature on particulate air pollution and asthma but primarily concerning children (4) (5) (6) . This literature may also prove informative as additional studies are reported, particularly of adults with asthma. Additionally, evidence elsewhere in the literature (1, 7) strongly links childhood exposure to ETS with asthma exacerbation in children and provides some evidence that ETS increases risk for the incidence of asthma.
Before considering the two questions, we describe the natural history of asthma as a disease and also briefly consider the role of active cigarette smoking and its relationship to asthma. The topic of asthma and ETS has been recently reviewed in the 1997 report of the California Environmental Protection Agency on ETS (1) and by Coultas (8) in 1998.
Natural History of Asthma
Asthma is primarily a disease with its origins in childhood (9) . Half of all asthma is diagnosed by 3 years of age and 80% by 6 years of age (10) . However, in many children, symptoms lessen with age, and many no longer carry the diagnosis of asthma as they move into the teen and young adult years (11) . Estimates suggest that 30-50% of all asthma with onset in childhood becomes asymptomatic by early adulthood, and not all wheezing illnesses in childhood reflect the presence of underlying asthma (11 There are some incident cases of asthma in adults, and the incidence of asthma begins to rise with age from the young adult years (9 passive cigarette smoking) may result in enough symptoms in an adult, formerly diagnosed with childhood asthma, to again pass the clinical threshold for a diagnosis. Because of faulty recollection of prior asthma, recrudescence of symptoms in adults may be interpreted as incidence of disease. Consequently, distinguishing onset of asthma in adulthood from recrudescence of childhood asthma may be difficult. Whether the distinction is directly relevant to preventing asthma in adults is unclear. For this review, we consider persons with asthma as potentially susceptible to ETS exposure, whether the asthma was incident in childhood or adulthood.
An additional methodological concern in interpreting the evidence on active and passive smoking and asthma is introduced by a form of selection bias that has been referred to as the healthy smoker effect (12) . This bias refers to the self-selection of persons with better respiratory health to be active smokers compared with those who remain nonsmokers. This form of bias may well apply to persons with childhood asthma. The degree to which asthmatic individuals in childhood have more severe symptoms and more severe disease may influence their probability of becoming active smokers; individuals who have greater levels of airways responsiveness or are very symptomatic may be less likely to become regular cigarette smokers. The resulting bias or healthy smoker effect will tend to obscure associations between active smoking and asthma, particularly in cross-sectional studies. This same type of bias may extend to cross-sectional studies of persons exposed to ETS, who may choose to avoid exposure to ETS, depending on their underlying state of respiratory health.
The available evidence shows that increased airways responsiveness does determine susceptibility to the harmful effects of active cigarette smoking, both in cross-sectional and longitudinal data, the latter providing stronger support for this selfselection (13) . The bulk of the cross-sectional data would support a relationship between smoking and increased levels of airways responsiveness despite the potential for selection bias in the studies (12) . However, with regard to an association of active smoking with asthma, the cross-sectional data are more equivocal. Cross-sectional studies, which are again subject to potential selection bias, have yielded both positive (14) and negative results (15) (16) (17) . Longitudinal data, which are less subject to the potential of selection bias, are unequivocal in supporting a role of active smoking in asthma occurrence (18, 19 1.6, 5.6) and current asthma (OR = 3.3; 95% CI: 1.7, 6.4) .
In a study of 3,914 Seventh Day Adventists, primarily nonsmokers, workplace exposure to ETS was a risk factor for incident asthma over a 10-year interval that began at a mean age of 56.5 years (23) . In this study, Greer This is a relatively small case-control study that may, in fact, underestimate the effect of active cigarette smoking as a risk factor for asthma. Recall bias, both in terms of timing of disease onset and exposure assessment, is a potential problem in this study.
Given the limited statistical power, the finding that the odds ratio for passive smoking is not significant at p < 0.05 is not surprising. Interpreting the magnitude of effect is also limited by the sample size, as the odds ratios are imprecisely estimated. With this constraint, the point estimate for the effect of passive smoking is about half that of active smoking. The relative similarity of the effects of active and passive smoking does not seem consistent with the relative doses of tobacco smoke associated with the two exposures. Although, the nonsignificant results might be predicted from the small sample size, the study data do suggest that workplace exposure, particularly as assessed in this study with four different exposure categories, may affect the risk of asthma in the adult population.
The Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) (25) also addressed ETS exposure and asthma in adults. The (30) (31) (32) , no change in reactivity (33, 34) or a decrease in reactivity (35) . Although a few studies showed adverse effects of exposure on function, the majority documented no significant effect on FEV, or measures of airway responsiveness.
Because many patients with bronchial asthma spontaneously report respiratory symptoms during or immediately after exposure to ETS, a relationship between ETSinduced symptoms, airway caliber, and airway responsiveness is plausible. Indeed, Stankus et al. (36) investigated the effects of a 2-hr exposure to ETS in 21 subjects with asthma who previously claimed respiratory symptoms from ETS exposure. In 7 of these 21 subjects, a fall in FEV, of > 20% was found. These findings suggest that there might be a subgroup of smoke-sensitive asthmatic subjects who develop acute airway obstruction after breathing ETS. A subsequent study by this group (32) partially confirmed the observation; 5 of 3 1 sensitive subjects with asthma and none of 39 smokesensitive subjects without asthma reacted to cigarette-smoke challenge with a > 20% fall from baseline FEVI. However, a history of symptoms induced by ETS has not been a consistently reproducible marker of pulmonary responsiveness to ETS. For example, Jorres and Magnussen (33) exposed a group of 24 asthmatics, 16 of whom had a history of passive smoke-induced respiratory symptoms, to ETS for 1 hr. ETS-induced symptoms could not be predicted from the history of passive smoke-related complaints. Airway responsiveness to methacholine, as estimated from spirometric or body plethysmographic measurements, was not influenced by the ETS challenge. In contrast to Stankus and colleagues (36), Jorres (31) . In addition, Menon and colleagues (31) found that pretreatment with albuterol or cromolyn can protect against ETS-induced airway reactivity. Perhaps protection by antioxidants accounts for some of the variability of the ETS-induced responses. Finally, Nowak and colleagues (37) observed that the nocturnal decrease in FEVy was more pronounced after ETS than after sham; this observation may be important for patients with bronchial asthma, for whom one of the Thus, ETS exposure has not yet been confirmed as a hazard for adults with asthma. Given the importance of this issue, there is a strong rationale for additional epidemiologic studies of ETS in the indoor environment. Clinical studies have the potential to be informative about the effects of ETS but require careful attention to protocol design and they cannot be blinded as to the exposure.
